Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Allergy Clin Immunol ; 139(6): 1923-1934.e17, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27913304

ABSTRACT

BACKGROUND: Numbers of blood leukocyte subsets are highly dynamic in childhood and differ greatly between subjects. Interindividual variation is only partly accounted for by genetic factors. OBJECTIVE: We sought to determine which nongenetic factors affect the dynamics of innate leukocytes and naive and memory lymphocyte subsets. METHODS: We performed 6-color flow cytometry and linear mixed-effects modeling to define the dynamics of 62 leukocyte subsets from birth to 6 years of age in 1182 children, with 1 to 5 measurements per subject. Subsequently, we defined the effect of prenatal maternal lifestyle-related or immune-mediated determinants, birth characteristics, and bacterial/viral exposure-related determinants on leukocyte subset dynamics. RESULTS: Functionally similar leukocyte populations were grouped by using unbiased hierarchical clustering of patterns of age-related leukocyte dynamics. Innate leukocyte numbers were high at birth and predominantly affected by maternal low education level. Naive lymphocyte counts peaked around 1 year, whereas most memory lymphocyte subsets more gradually increased during the first 4 years of life. Dynamics of CD4+ T cells were predominantly associated with sex, birth characteristics, and persistent infections with cytomegalovirus (CMV) or EBV. CD8+ T cells were predominantly associated with CMV and EBV infections, and T-cell receptor γδ+ T cells were predominantly associated with premature rupture of membranes and CMV infection. B-cell subsets were predominantly associated with sex, breast-feeding, and Helicobacter pylori carriership. CONCLUSIONS: Our study identifies specific dynamic patterns of leukocyte subset numbers, as well as nongenetic determinants that affect these patterns, thereby providing new insights into the shaping of the childhood immune system.


Subject(s)
Leukocytes/classification , Cell Count , Child , Child, Preschool , Cytomegalovirus Infections/immunology , Epstein-Barr Virus Infections/immunology , Female , Humans , Infant , Infant, Newborn , Leukocytes/immunology , Male , Maternal Health , Pregnancy
2.
J Infect Dis ; 213(2): 233-42, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26142434

ABSTRACT

BACKGROUND: Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) induce effector memory T-cell expansions, which are variable and potentially depend on the age at primary exposure and coinfections. We evaluated the T-cell compartment and herpesvirus infections in 6-year-old children. METHODS: T-cell subsets and immunoglobulin G seropositivity for CMV, EBV, herpes-simplex virus 1, and varicella-zoster virus were studied in 1079 6-year-old children. A random subgroup of 225 children was evaluated for CMV and EBV seropositivity before 2 years of age and for vaccination responses against measles and tetanus. RESULTS: CMV and EBV infections were associated with significant expansions of CD27(-) and CD27(+) effector memory T cells, respectively. These expansions were enhanced in CMV-EBV-coinfected children and were independent of varicella-zoster virus or herpes-simplex virus 1 coinfection. Naive and central memory T-cell numbers were not affected, nor were anti-tetanus and anti-measles immunoglobulin G levels. Children infected before 2 years of age showed smaller effector memory T-cell expansions than those infected between 2 and 6 years of age. CONCLUSIONS: CMV- and EBV-related T-cell expansions do not impair naive T-cell numbers or maintenance of protective responses against nonrelated pathogens. Duration of infection was not directly related to larger expansions of effector memory T cells in children, suggesting that other mechanisms affect these expansions at later age.


Subject(s)
Cytomegalovirus/physiology , Herpesvirus 4, Human/physiology , Measles Vaccine/immunology , T-Lymphocyte Subsets/physiology , Tetanus Antitoxin/immunology , Cell Differentiation , Child , Child, Preschool , Herpesvirus 1, Human/immunology , Herpesvirus 3, Human/immunology , Humans , Measles/prevention & control , Tetanus/prevention & control , Vaccination
3.
AIDS ; 29(14): 1745-56, 2015 Sep 10.
Article in English | MEDLINE | ID: mdl-26372381

ABSTRACT

OBJECTIVES: With the introduction of combined antiretroviral therapy (cART), HIV-infected children can reach adulthood with minimal clinical complications. However, long-term HIV and cART in adults are associated with immunosenescence and end-organ damage. Long-term consequences of HIV and cART in children are currently unknown. DESIGN AND METHOD: We studied 69 HIV-infected children and adolescents under cART (0-23 years) for the occurrence of subclinical immunological aberrations in blood B and T cells, using detailed flow cytometric immunophenotyping and molecular analyses. RESULTS: Children with undetectable plasma HIV viral loads for more than 1 year showed near-normal to normal CD4 T-cell numbers and near-normal numbers of most class-switched memory B cells. Furthermore, expansions of aberrant CD21 B cells contracted in patients with virus suppression. In contrast, CD8 effector T cells were increased, and CD4 memory T cells, Vγ9Vδ2 T cells and CD27IgA memory B cells were decreased and did not normalize under ART. Moreover, Vγ9Vδ2 T cells showed defects in their T-cell receptor repertoire selection. CONCLUSION: Our results show the effectiveness of current cART to enable the build-up of phenotypically diverse B-cell and T-cell memory in HIV-infected children. However, several subclinical immune abnormalities were detected, which were partially caused by defective immune maturation. These persistent abnormalities were most severe in adolescents and therefore warrant long-term follow-up of HIV-infected children. Early identification of such immune defects might provide targets for monitoring future treatment optimization.


Subject(s)
Anti-Retroviral Agents/therapeutic use , B-Lymphocytes/immunology , HIV Infections/drug therapy , HIV Infections/pathology , Lymphocyte Subsets/immunology , T-Lymphocytes/immunology , Adolescent , Child , Child, Preschool , Female , Flow Cytometry , HIV Infections/virology , HIV-1/isolation & purification , Humans , Immunophenotyping , Infant , Male , Young Adult
4.
Proteomics ; 10(12): 2348-58, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20394078

ABSTRACT

We present here the results from MS peptide profiling experiments of prostate carcinoma patients and controls with a specific focus on protease activity-related protein fragments. After purification with surface-active magnetic beads, MALDI-TOF profiling experiments were performed on tryptic digests of serum samples of prostate cancer patients with metastases (n=27) and controls (n=30). This resulted in the reproducible detection of eight differentially expressed peptides, which were then identified by nanoLC-MALDI-TOF/TOF and confirmed by MALDI-FTMS exact mass measurements. All differentially expressed peptides are derived from two homologous parts of human serum albumin; two of the eight peptides were tryptic and six were nontryptic. The presence of the nontryptic fragments indicates that a proteolysis process occurs which is not mediated by trypsin. Since the nontryptic fragments were found at significantly higher levels in control samples compared with metastases samples, it is proposed that a specific proteolytic inhibition process is in effect in the serum of prostate cancer patients. Experiments using synthetic peptides showed that this proteolytic activity occurs ex vivo and is sequence specific. Importantly, the observed prostate carcinoma-related inhibition of the proteolysis was reproduced ex vivo using synthetic peptides.


Subject(s)
Gene Expression Regulation, Neoplastic , Peptide Hydrolases/blood , Prostatic Neoplasms/blood , Prostatic Neoplasms/enzymology , Humans , Male , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
5.
J Proteome Res ; 9(1): 268-74, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19874049

ABSTRACT

Up until today, no proteomics approaches have been described for heart muscle development. We describe a proteomics method to study the proteome of different heart structures at three stages of chicken embryonic development. For this purpose, a combination of gel separation, nanoLC separation and mass spectrometry was used. With this method, we identified in total 267 proteins in different tissue structures of chicken heart. We observed differences in protein abundance for a number of proteins between the different tissue structures and time points of development using spectral counting as a semiquantitative measure of protein abundance. For myosin-heavy chain 6, myosin-heavy chain 7, titin, connectin, collagen alpha-1, and xin, differences in protein levels for the different stages and structures (great arteries, outflow tract and ventricles) have been observed. A pathway analysis is performed in which the identified proteins are related to theoretical protein networks. Most prominent was the 'cardiovascular system development and function' network with the abundantly present proteins myosin 6 and myosin 7. We showed that myosin 6 is highly regulated in a stage and heart tissue specific manner. In conclusion, this method can be used to study changes in protein levels of chicken heart tissue in a spatiotemporal manner.


Subject(s)
Cardiovascular System/embryology , Cardiovascular System/growth & development , Myocardium/metabolism , Proteomics/methods , Animals , Chick Embryo , Heart/embryology , Heart/growth & development , Myosins/metabolism , Organ Specificity , Signal Transduction
6.
Biochem Biophys Res Commun ; 370(2): 225-9, 2008 May 30.
Article in English | MEDLINE | ID: mdl-18361919

ABSTRACT

Pdx-1 is a key regulator of glucose-stimulated insulin gene transcription in beta-cells. The regulation of Pdx-1 in response to glucose has previously been associated with a remarkable shift in electrophoretic mobility on SDS-PAGE from 31 to 45kDa. This has been attributed to different post-translational modifications including phosphorylation, sumoylation or glycosylation. However, and in contrast with previous studies, we describe in this paper that Pdx-1 produced in Escherichia coli, by in vitro transcription/translation or exogenously expressed in eukaryotic cells, migrates with an apparent molecular mass of 45kDa despite a calculated mass of 31kDa. Moreover, we show that the migration of endogenous Pdx-1 obtained from a mouse beta-cell line as well as from human primary islets is not dependent on glucose concentration. Taken together, these data, validated by mass spectrometry techniques, establish that anomalous migration of Pdx-1 on SDS-PAGE does not result from post-translational modifications.


Subject(s)
Artifacts , Electrophoresis, Polyacrylamide Gel , Homeodomain Proteins/chemistry , Homeodomain Proteins/metabolism , Protein Processing, Post-Translational , Trans-Activators/chemistry , Trans-Activators/metabolism , Animals , Cell Line , Escherichia coli/genetics , Glucose/metabolism , Homeodomain Proteins/genetics , Humans , Mice , Molecular Weight , Rats , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Trans-Activators/genetics
7.
Proteomics ; 8(1): 45-61, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18095365

ABSTRACT

Quercetin has been shown to act as an anticarcinogen in experimental colorectal cancer (CRC). The aim of the present study was to characterize transcriptome and proteome changes occurring in the distal colon mucosa of rats supplemented with 10 g quercetin/kg diet for 11 wk. Transcriptome data analyzed with Gene Set Enrichment Analysis showed that quercetin significantly downregulated the potentially oncogenic mitogen-activated protein kinase (Mapk) pathway. In addition, quercetin enhanced expression of tumor suppressor genes, including Pten, Tp53, and Msh2, and of cell cycle inhibitors, including Mutyh. Furthermore, dietary quercetin enhanced genes involved in phase I and II metabolism, including Fmo5, Ephx1, Ephx2, and Gpx2. Quercetin increased PPARalpha target genes, and concomitantly enhanced expression of genes involved in mitochondrial fatty acid (FA) degradation. Proteomics performed in the same samples revealed 33 affected proteins, of which four glycolysis enzymes and three heat shock proteins were decreased. A proteome-transcriptome comparison showed a low correlation, but both pointed out toward altered energy metabolism. In conclusion, transcriptomics combined with proteomics showed that dietary quercetin evoked changes contrary to those found in colorectal carcinogenesis. These tumor-protective mechanisms were associated with a shift in energy production pathways, pointing at decreased cytoplasmic glycolysis and toward increased mitochondrial FA degradation.


Subject(s)
Colorectal Neoplasms/prevention & control , Fatty Acids/metabolism , Gene Expression Profiling , Glycolysis/physiology , Intestinal Mucosa/metabolism , Mitochondria/metabolism , Proteome/metabolism , Quercetin/administration & dosage , Animals , Colon/metabolism , Colorectal Neoplasms/metabolism , Diet , Down-Regulation/physiology , Intestinal Mucosa/chemistry , Male , Mitochondria/chemistry , Rats , Rats, Inbred F344
8.
Mol Cell Proteomics ; 6(7): 1147-57, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17360931

ABSTRACT

The identification of angiogenesis-related proteins is important for the development of new antiangiogenic therapies, and such proteins are potential new biomarkers for gliomas. The aim of this study was to identify proteins that are exclusively present in glioma neovasculature and not in the vasculature of normal brain. We combined advanced proteomics techniques to compare the expression profiles of microdissected blood vessels from glioma with blood vessels of normal control brain samples. We measured the enzymatic generated peptide profiles from these microdissected samples by MALDI-FTMS. Subsequently, the samples were fractionated by nano-LC prior to MALDI-TOF/TOF. This combined approach enabled us to identify four proteins that appeared to be exclusively expressed in the glioma blood vessels. Two of these proteins, fibronectin and colligin 2, were validated on tissue sections using specific antibodies. We found that both proteins are present in active angiogenesis in glioma, other neoplasms, and reactive conditions in which neoangiogenesis takes place. This work proves that gel-free mass spectrometric techniques can be used on relatively small numbers of cells generated by microdissection procedures to successfully identify differentially expressed proteins.


Subject(s)
Biomarkers, Tumor/metabolism , Brain Neoplasms/blood supply , Brain Neoplasms/metabolism , Glioma/blood supply , Glioma/metabolism , Adult , Blood Vessels/metabolism , Carrier Proteins/metabolism , Chromatography, Liquid , Female , Fibrinogen/metabolism , Fibronectins/metabolism , Glycoproteins , Humans , Infant , Male , Microdissection , Middle Aged , Nanotechnology , Neovascularization, Pathologic/metabolism , Peptides/analysis , Proteomics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...